Author: Peter

blood cancer treatments carry a high price tag that prevents them from being considered cost effective… drug costs have grown exponentially...new drugs coming to market soon that are almost all priced above $100,000 per year of treatment. This is becoming very unaffordable and unsustainable."

Many states implement unlawful and life-threatening restrictions on Medicaid coverage for the hepatitis C virus drug, sofosbuvir…limited treatment to HCV patients with advanced fibrosis or cirrhosis… treating earlier to prevent these liver-related complications seems counterintuitive…

1. No chain pharmacies allowed

2. Generic substitution

3. Non-controlled prescription expiration

4. Prescriptive authority

5. Technician-to-pharmacist ratios

6. No Rx means no pseudoephedrine

Clark County Medical Society announced the 2015 recipients of the Third Annual Winged Heart Award (Tammy Wert RN - University Medical Center; Candlelighters Childhood Cancer Foundation) and the Student Rising Star Award.(Lindsey Murphy University of Nevada School of Medicine; Robert Wills - Touro University Nevada College of Medicine)...

high-cost medications...will drive up health care inflation…issue of drug pricing presents an opportunity for pharmacists to get more involved with prescribers and patients in promoting cost-effective medication therapy...another reason for pharmacists to become an active part of the health care team.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Anne Burns RPh Vice President of Professional Affairs at the American Pharmacists Association talks about the changes that pharmacists can expect to see in the coming years.

pharmacists can take the lead in improving care transitions,.. for heart failure patients.
They monitored for compliance with 3 core HF measures:
(1) Did patients receive discharge instructions?
(2) Was left ventricular systolic (LVS) evaluated?
(3) Was an ACE inhibitor or ARB prescribed for LVS dysfunction?

market for biosimilars could hit $20 billion by the end of the year… biologics currently comprise between 17–20% of the pharmaceutical arena, with a value of nearly $200 billion… biologic drugs may replace 70% of chemical drugs…the 30% to 50% reduction in biosimilar prices when compared with branded biologics may.. generate considerable…savings

Publix pharmacy technician has been fired and arrested after confessing to stealing Vicodin to pay for her gas money and other car expenses….she had been stealing the tablets…for about a year…She allegedly sold the pills to children…